Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

Published:2012-08-01 Issue:25 Volume:18 Page:3793-3803
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:curr pharm des

Author:

Mulier Stefaan,Claes Jean-Pierre,Dierieck Vincent,Amiel Jean-Olivier,Pahaut Jean-Philippe,Marcelis Luc,Bastin Fabienne,Vanderbeeken Denis,Finet Claude,Cran Sophie,Velu Thierry

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Hyperthermia for Cancer Treatment: Various Techniques and Recent Advancement;International Journal of Advanced Pharmaceutical Sciences and Research;2023-12-30

2. Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer;Frontiers in Oncology;2023-05-23

3. HIPEC for gynaecological malignancies: A last update (Review);Medicine International;2023-05-04

4. Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes;Cancers;2022-12-06

5. Cytoreductive Surgery (CRS) Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Platinum-Sensitive Recurrence Epithelial Ovarian Cancer With HRR Mutation: A Phase III Randomized Clinical Trial;Technology in Cancer Research & Treatment;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP